SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Trading update

30 Apr 2021 07:00

RNS Number : 1450X
Rotork PLC
30 April 2021
 

30 April 2021

Rotork Plc

Trading update

Activity continued to improve in the first quarter. COVID-19 uncertainty remains

Rotork plc ("Rotork"), the global flow control and instrumentation group, today issues the following trading update covering the first quarter period from 1 January to 4 April 2021 ahead of its Annual General Meeting to be held later today.

COVID-19 update

All our production facilities are currently open and operating at close to normal output levels. Several were however impacted by COVID-19 closures early in the period. Whilst every effort is being made to keep our facilities open, we will not hesitate to close them if required or if we believe there is any risk to our colleagues or their families or friends.

Trading update

Performance in the period was in-line with our expectations. Order intake (on an organic constant currency basis, "OCC") was mid-single digits below the 2020 comparator, which was only modestly affected by COVID-19. Revenue was up mid-single digits year-on-year on an OCC basis, in part reflecting the weighting of first half 2020 sales to the second quarter.

Like many global businesses we are seeing elevated logistics costs and disruption to some supply routes as well as commodity cost escalation. In order to mitigate the higher logistics costs we introduced temporary surcharges on the most affected routes earlier this year. Commodity cost inflation is anticipated to be largely offset by our January price increase.

Our Growth Acceleration Programme ("GAP") is on track. We continue to see the benefits of our market re-alignment which was completed a year ago. Our investments in Rotork Site Services and in innovation and new product development are also yielding benefits. Our GAP priorities in 2021 include supply chain optimisation and our IT solutions roll-out.

Rotork continues to be highly cash generative with a strong balance sheet and net cash of £190.8m at 4 April 2021 (£178.1m at 31 December 2020). The current cash position reflects the decision to pay the £54.9m dividend (6.3p per share) in respect of 2020 in one payment (on 21 May 2021).

We continue to strengthen our business and are well placed to benefit from recovering demand. Whilst the outlook for our end markets is improved, COVID-19 related uncertainty remains. We remain committed to delivering sustainable mid to high single digit revenue growth and mid 20s adjusted operating profit margins over time.

Rotork will publish 2021 half-year results on Tuesday 3 August 2021.

Enquiries:

Rotork plc Tel: +44 (0)1225 733 200

Kevin Hostetler, Chief Executive

Jonathan Davis, Finance Director

Andrew Carter, Investor Relations Director

 

FTI Consulting Tel: + 44 (0)20 3727 1340

Nick Hasell / Susanne Yule

 

About Rotork

Rotork is a market-leading global provider of mission-critical flow control and instrumentation solutions for oil & gas, water and wastewater, power, chemical, process and industrial applications. We help customers around the world to improve efficiency, reduce emissions, minimise their environmental impact and assure safety. Rotork employs about 3,400 people, has manufacturing facilities in 20 locations and serves 173 countries through a global service network. Its shares have a premium listing on the London Stock Exchange (symbol: ROR) and are a constituent of the FTSE 250 index. For more information please visit www.rotork.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLASAIAFIL
Date   Source Headline
12th Mar 202510:49 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNS2024 full year results
11th Mar 20257:00 amRNSShare buyback programme
11th Mar 20257:00 amRNSAcquisition of Noah Actuation
7th Mar 20251:35 pmRNSHolding(s) in Company
3rd Mar 20259:02 amRNSTotal Voting Rights
11th Feb 20254:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:45 amRNSTotal Voting Rights
13th Jan 20254:18 pmRNSDirector/PDMR Shareholding
2nd Jan 20259:43 amRNSTotal Voting Rights
16th Dec 20243:34 pmRNSDirector/PDMR Shareholding
11th Dec 20244:40 pmRNSDirector/PDMR Shareholding
9th Dec 20241:20 pmRNSCompletion of Share Buyback Programme
6th Dec 20245:43 pmRNSTransaction in Own Shares
5th Dec 20245:15 pmRNSTransaction in Own Shares
4th Dec 20245:19 pmRNSTransaction in Own Shares
3rd Dec 20245:10 pmRNSTransaction in Own Shares
3rd Dec 202411:50 amRNSBoard Committee and Board Role Changes
2nd Dec 20245:12 pmRNSTransaction in Own Shares
2nd Dec 20249:27 amRNSTotal Voting Rights
29th Nov 20245:38 pmRNSTransaction in Own Shares
28th Nov 20245:20 pmRNSTransaction in Own Shares
27th Nov 20245:40 pmRNSTransaction in Own Shares
26th Nov 20245:25 pmRNSTransaction in Own Shares
25th Nov 20245:14 pmRNSTransaction in Own Shares
22nd Nov 20245:17 pmRNSTransaction in Own Shares
21st Nov 20245:04 pmRNSTransaction in Own Shares
20th Nov 20245:09 pmRNSTransaction in Own Shares
20th Nov 202411:00 amRNSDirectorate Change
20th Nov 20247:00 amRNSTrading Update
19th Nov 20245:07 pmRNSTransaction in Own Shares
18th Nov 20245:21 pmRNSTransaction in Own Shares
15th Nov 20245:11 pmRNSTransaction in Own Shares
14th Nov 20245:15 pmRNSTransaction in Own Shares
13th Nov 20245:16 pmRNSTransaction in Own Shares
12th Nov 20245:33 pmRNSTransaction in Own Shares
12th Nov 202412:44 pmRNSDirector/PDMR Shareholding
11th Nov 20245:08 pmRNSTransaction in Own Shares
8th Nov 20245:22 pmRNSTransaction in Own Shares
7th Nov 20245:12 pmRNSTransaction in Own Shares
7th Nov 202412:21 pmRNSShare Buy-Back Programme
1st Nov 20249:17 amRNSTotal Voting Rights
25th Oct 20245:36 pmRNSTransaction in Own Shares
24th Oct 20245:10 pmRNSTransaction in Own Shares
23rd Oct 20245:07 pmRNSTransaction in Own Shares
22nd Oct 20245:09 pmRNSTransaction in Own Shares
21st Oct 20244:53 pmRNSTransaction in Own Shares
18th Oct 20244:54 pmRNSTransaction in Own Shares
17th Oct 20245:07 pmRNSTransaction in Own Shares
16th Oct 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.